8-K Latigo Biotherapeutics, Inc. 2026-09-03: filing_items
| Value | {"items": {"2.02": "Results of Operations and Financial Condition", "9.01": "Financial Statements and Exhibits"}, "value": "2.02,9.01"} |
|---|---|
| Period | (as of 2026-09-03) |
| Status | current |
| Entity | 8-K Latigo Biotherapeutics, Inc. 2026-09-03 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
Retrieved: 2026-09-03T22:24:04.003145+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/99c9cf7e-f122-4026-ab5c-491722ce2a9c
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference:
https://www.sec.gov/Archives/edgar/data/2056611/000119312526381912/0001193125-26-381912-index.htmRetrieved: 2026-09-03T22:24:04.003145+02:00
Raw response sha256:
63917fa0f4ff93aabf0d6321942db0e8…Cite as: FACTANKER, https://factanker.com/fact/99c9cf7e-f122-4026-ab5c-491722ce2a9c
History
- no predecessors — first report